Polar Capital’s DexCom DXCM Stock Holding History

Polar Capital’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$13.1M	Sell	126,660 -69,412	-35%	-$7.25M	0.1%	167
2020 Q2	$19.9M	Sell	196,072 -1,836	-0.9%	-$164K	0.17%	132
2020 Q1	$13.3M	Buy	+197,908	New	+$12.3M	0.14%	152
2019 Q4	–	Sell	-768,368	Closed	-$28.7M	–	288
2019 Q3	$28.7M	Buy	768,368 +473,168	+160%	+$18.4M	0.26%	116
2019 Q2	$11.1M	Sell	295,200 -784,800	-73%	-$24.7M	0.1%	180
2019 Q1	$32.2M	Buy	+1,080,000	New	+$38M	0.3%	116
2017 Q3	–	Sell	-160,400	Closed	-$2.93M	–	241
2017 Q2	$2.93M	Hold	160,400	–	–	0.04%	208
2017 Q1	$3.4M	Sell	160,400 -1,165,992	-88%	-$22.8M	0.05%	206
2016 Q4	$19.8M	Buy	+1,326,392	New	+$23.5M	0.32%	106
2016 Q3	–	Sell	-60,652	Closed	-$1.2M	–	263
2016 Q2	$1.2M	Sell	60,652 -835,348	-93%	-$14.2M	0.02%	238
2016 Q1	$15.2M	Buy	+896,000	New	+$15M	0.29%	102
2014 Q1	–	Sell	-1,940,000	Closed	-$17.2M	–	269
2013 Q4	$17.2M	Hold	1,940,000	–	–	0.41%	90
2013 Q3	$13.7K	Buy	+1,940,000	New	+$12.3M	0.37%	97

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Polar Capital's DXCM Position: Q3 2020 in Review

Polar Capital reduced its DexCom (DXCM) stake by 35% in Q3 2020, selling an estimated $7.25M and leaving 126,660 shares worth $13.1M. The position accounts for 0.1% of the portfolio, ranked #167.

Polar Capital first reported a position in DXCM in Q3 2013 and has held it in 13 quarters since. The position peaked at $32.2M in Q1 2019. 727 funds tracked by Wall St. Rank hold DXCM as of Q3 2020.

Polar Capital held 126,660 shares of DexCom worth $13.1M as of Q3 2020.
Polar Capital sold 69,412 DexCom shares in Q3 2020, an estimated $7.25M.
DexCom made up 0.1% of Polar Capital's portfolio in Q3 2020, its #167 holding.
Polar Capital first reported a position in DexCom in Q3 2013 and has held it in 13 quarters since.
Polar Capital's DexCom position peaked at $32.2M in Q1 2019.
727 funds tracked by Wall St. Rank held DexCom as of Q3 2020.

Based on Polar Capital's 13F filing for Q3 2020, filed 16 Nov 2020.